Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report

Introduction. Primary extragonadal germ cell tumors (EGCTs) are a very rare clinical encounter most commonly reported in males. Among females, the placenta, pelvis, uterus, brain, and mediastinum are the most common extragonadal sites and predominantly display nondysgerminoma histology. In this repo...

Full description

Saved in:
Bibliographic Details
Main Authors: Biruck Gashawbeza, Bethel Dereje, Ferid A. Abubeker
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2024/6465387
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546203021082624
author Biruck Gashawbeza
Bethel Dereje
Ferid A. Abubeker
author_facet Biruck Gashawbeza
Bethel Dereje
Ferid A. Abubeker
author_sort Biruck Gashawbeza
collection DOAJ
description Introduction. Primary extragonadal germ cell tumors (EGCTs) are a very rare clinical encounter most commonly reported in males. Among females, the placenta, pelvis, uterus, brain, and mediastinum are the most common extragonadal sites and predominantly display nondysgerminoma histology. In this report, we present a case of a primary cervical dysgerminoma in a young female patient. Case Report. An 18-year-old nulligravid woman presented with a 12-month history of vaginal bleeding and discharge. Routine blood tests and serum levels of tumor markers were within normal limits. The chest X-ray was normal. A high-resolution pelvic MRI showed a well-defined lobulated cervicovaginal mass measuring 8×6×5 cm expanding into the vaginal canal with mild homogenous contrast enhancement. An incisional biopsy was performed vaginally under anesthesia, and histologic findings were consistent with dysgerminoma. A repeat follow-up pelvic MRI was done and showed a reduction in the size of the mass by more than 70%. The patient was treated with 4 cycles of bleomycin, etoposide, and cisplatin chemotherapy. Additional external pelvic beam radiation treatment was administered for a partial response. After 3 months of radiotherapy, a contrast abdominopelvic CT scan showed a recurrent cervicovaginal mass with extension to the pelvic sidewalls. The patient was initiated with ifosfamide, paclitaxel, and cisplatin (ITP) as second-line chemotherapy for a recurrent germ cell tumor but later died from hydronephrosis, chronic anemia, and sepsis. Conclusion. The uterine cervix is a very unusual site for primary dysgerminoma and can have a very aggressive clinical course. A high index of suspicion and an exhaustive workup are necessary to reach a diagnosis, particularly in a young patient presenting with a cervical lesion.
format Article
id doaj-art-73ef0eb455c0467f9d9f1d12aaf281e4
institution Kabale University
issn 2090-6692
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-73ef0eb455c0467f9d9f1d12aaf281e42025-02-03T07:23:39ZengWileyCase Reports in Obstetrics and Gynecology2090-66922024-01-01202410.1155/2024/6465387Primary Dysgerminoma of the Uterine Cervix: A Rare Case ReportBiruck Gashawbeza0Bethel Dereje1Ferid A. Abubeker2Department of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyIntroduction. Primary extragonadal germ cell tumors (EGCTs) are a very rare clinical encounter most commonly reported in males. Among females, the placenta, pelvis, uterus, brain, and mediastinum are the most common extragonadal sites and predominantly display nondysgerminoma histology. In this report, we present a case of a primary cervical dysgerminoma in a young female patient. Case Report. An 18-year-old nulligravid woman presented with a 12-month history of vaginal bleeding and discharge. Routine blood tests and serum levels of tumor markers were within normal limits. The chest X-ray was normal. A high-resolution pelvic MRI showed a well-defined lobulated cervicovaginal mass measuring 8×6×5 cm expanding into the vaginal canal with mild homogenous contrast enhancement. An incisional biopsy was performed vaginally under anesthesia, and histologic findings were consistent with dysgerminoma. A repeat follow-up pelvic MRI was done and showed a reduction in the size of the mass by more than 70%. The patient was treated with 4 cycles of bleomycin, etoposide, and cisplatin chemotherapy. Additional external pelvic beam radiation treatment was administered for a partial response. After 3 months of radiotherapy, a contrast abdominopelvic CT scan showed a recurrent cervicovaginal mass with extension to the pelvic sidewalls. The patient was initiated with ifosfamide, paclitaxel, and cisplatin (ITP) as second-line chemotherapy for a recurrent germ cell tumor but later died from hydronephrosis, chronic anemia, and sepsis. Conclusion. The uterine cervix is a very unusual site for primary dysgerminoma and can have a very aggressive clinical course. A high index of suspicion and an exhaustive workup are necessary to reach a diagnosis, particularly in a young patient presenting with a cervical lesion.http://dx.doi.org/10.1155/2024/6465387
spellingShingle Biruck Gashawbeza
Bethel Dereje
Ferid A. Abubeker
Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
Case Reports in Obstetrics and Gynecology
title Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
title_full Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
title_fullStr Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
title_full_unstemmed Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
title_short Primary Dysgerminoma of the Uterine Cervix: A Rare Case Report
title_sort primary dysgerminoma of the uterine cervix a rare case report
url http://dx.doi.org/10.1155/2024/6465387
work_keys_str_mv AT biruckgashawbeza primarydysgerminomaoftheuterinecervixararecasereport
AT betheldereje primarydysgerminomaoftheuterinecervixararecasereport
AT feridaabubeker primarydysgerminomaoftheuterinecervixararecasereport